Arxis, Inc. (NASDAQ:ARXS) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Arxis, Inc. (NASDAQ:ARXSGet Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and ten have given a buy rating to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $53.7273.

A number of research firms have recently weighed in on ARXS. Morgan Stanley restated an “overweight” rating and set a $62.00 price target on shares of Arxis in a report on Monday, August 3rd. Royal Bank Of Canada increased their target price on shares of Arxis from $46.00 to $50.00 and gave the stock a “sector perform” rating in a research report on Friday, July 31st. Citigroup raised their target price on Arxis from $61.00 to $67.00 and gave the company a “buy” rating in a report on Thursday, August 13th. Weiss Ratings assumed coverage on Arxis in a research report on Monday, August 3rd. They issued a “sell (d+)” rating for the company. Finally, Wells Fargo & Company upped their target price on Arxis from $52.00 to $63.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 4th.

Read Our Latest Analysis on ARXS

Arxis Stock Performance

NASDAQ:ARXS opened at $52.45 on Friday. The stock has a 50 day moving average price of $50.35. Arxis has a 52 week low of $33.15 and a 52 week high of $61.50. The firm has a market capitalization of $21.90 billion and a P/E ratio of 655.62. The company has a quick ratio of 3.79, a current ratio of 5.21 and a debt-to-equity ratio of 0.38.

Arxis (NASDAQ:ARXSGet Free Report) last posted its earnings results on Wednesday, July 29th. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.35. The business had revenue of $500.73 million during the quarter. The firm’s revenue was up 25.0% compared to the same quarter last year. As a group, sell-side analysts forecast that Arxis will post 0.57 earnings per share for the current fiscal year.

Institutional Trading of Arxis

Several hedge funds have recently added to or reduced their stakes in the business. The Manufacturers Life Insurance Company acquired a new stake in Arxis in the 2nd quarter valued at approximately $207,000. Amundi acquired a new position in shares of Arxis during the second quarter worth approximately $358,000. IMC Chicago LLC bought a new stake in shares of Arxis in the second quarter valued at approximately $1,146,000. Grandeur Peak Global Advisors LLC acquired a new stake in shares of Arxis in the second quarter worth $2,740,000. Finally, BlueCrest Capital Management Ltd acquired a new stake in shares of Arxis in the second quarter worth $7,389,000.

Arxis Company Profile

(Get Free Report)

We are a leading designer and manufacturer of proprietary, mission-critical electronic and mechanical components engineered for cutting-edge performance in extreme environments. Leveraging significant intellectual property (“IP”) and world-class engineering capabilities, we design and deliver innovative solutions that address some of our customers’ most complex performance needs. Arxis is the result of a deliberate and disciplined strategy executed by our sponsor, Arcline, and the Arxis management team to create a purpose-built, cohesive business through targeted acquisitions with similar product and end market characteristics.

Recommended Stories

Analyst Recommendations for Arxis (NASDAQ:ARXS)

Receive News & Ratings for Arxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arxis and related companies with MarketBeat.com's FREE daily email newsletter.